Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5cd84f92e5e2ff95dfd19e4e329db3b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755 |
filingDate |
2009-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22bd6aa1ddee73e2a9c5705ce7309c0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4fd0d046185df7580f839c9ab23e43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a2df9c06a48050a946ec83da3a3eeb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6115be614ca7163854437006da3b6aa6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3e4ceb5ecc01d8b3956c8edcdbf16fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a0ae2617cea9c523d19ba971921b64c |
publicationDate |
2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20110033242-A |
titleOfInvention |
Factor VIII Mutein with Reduced Immunogenicity |
abstract |
The present invention is directed to modified Factor VIII molecules in which N-linked glycosylation is reduced and immunogenicity is reduced. The invention also relates to methods of using modified Factor VIII molecules to treat, for example, patients with hemophilia. |
priorityDate |
2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |